CD8A and neoplasm: Specific stromal subtypes, such as CAFs, can augment the cytotoxic efficacy of CD8+ T cells and NK cells by releasing chemokines resembling CXCL9 and CXCL10, which promote the recruitment of immune cells to the tumor location [198–201].